The document discusses COVID-19 in children. It notes that fewer cases have been reported in children than adults, with children representing about 14% of total cases. As of May 2021, over 3.9 million children in the US had tested positive. Most cases in children are mild and treatment consists of supportive care. The virus is transmitted through respiratory droplets and contact or surfaces. Family clustering appears to play a role in transmission between children. Symptoms in children tend to be mild and include cough, fever, and pharyngeal erythema.
Multisystem inflammatory syndrome in children and adolescents with COVID-19Chaitanya Nukala
Multisystem Inflammatory Syndrome in children (MIS-C) OR
Pediatric Multisystem Inflammatory Syndrome [PMIS] OR
pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 [PIMS-TS], OR
pediatric hyper inflammatory syndrome, or pediatric hyper inflammatory shock) OR
KAWA-COVID
Multisystem inflammatory syndrome in children and adolescents with COVID-19Chaitanya Nukala
Multisystem Inflammatory Syndrome in children (MIS-C) OR
Pediatric Multisystem Inflammatory Syndrome [PMIS] OR
pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 [PIMS-TS], OR
pediatric hyper inflammatory syndrome, or pediatric hyper inflammatory shock) OR
KAWA-COVID
COVID-19 is a global infectious disease pandemic with high morbidity and mortality for at risk individuals. This slide is intended for the medical students, medical doctors and those in training for masters of medicine (MMED).
Brief presentation about COVID19 diagnosis ,management and discharge criteria from isolation. Short Discussion about guideline given by Nepal medical council and TUTH for management.
What is Fifth disease, what is erythema infectiosum What is the causative factor, pathophysiology ,clinical presentation ,diagnosis ,laboratory investigations ,treatment , precautions and prognosis ,
The Corona virus pandemic has costed a lot of lives through out the world.
Here are some in formations about what is known so far.
It includes cause, Spread, Signs and Symptoms.
it also has the ongoing myths about corona virus.
congenital cytomegalovirus infection is a major problem in children. severe morbidity also in some cases mortality can occur due to this infection. this presentation has highlighted updates on this topic in short.
Pneumonia is an infection of the lungs. The air sacs in the lungs (called alveoli) fill up with pus and other fluid, which makes it hard for oxygen to reach the bloodstream.
Someone with pneumonia may have a fever, cough, or trouble breathing.
Multisystem inflammatory syndrome in children (MIS-C) in COVID19صقري بن شاهين
Multisystem inflammatory syndrome in children (MIS-C) as found recently in pandemic covid19 (SARS-CoV-2) within pediatric field as it was labeled as Kawasaki like disease.
objectives:
Introduction
Definition
Epidemiology
Pathophysiology
Clinical presentaion
Evaluation
management
COVID-19 is a global infectious disease pandemic with high morbidity and mortality for at risk individuals. This slide is intended for the medical students, medical doctors and those in training for masters of medicine (MMED).
Brief presentation about COVID19 diagnosis ,management and discharge criteria from isolation. Short Discussion about guideline given by Nepal medical council and TUTH for management.
What is Fifth disease, what is erythema infectiosum What is the causative factor, pathophysiology ,clinical presentation ,diagnosis ,laboratory investigations ,treatment , precautions and prognosis ,
The Corona virus pandemic has costed a lot of lives through out the world.
Here are some in formations about what is known so far.
It includes cause, Spread, Signs and Symptoms.
it also has the ongoing myths about corona virus.
congenital cytomegalovirus infection is a major problem in children. severe morbidity also in some cases mortality can occur due to this infection. this presentation has highlighted updates on this topic in short.
Pneumonia is an infection of the lungs. The air sacs in the lungs (called alveoli) fill up with pus and other fluid, which makes it hard for oxygen to reach the bloodstream.
Someone with pneumonia may have a fever, cough, or trouble breathing.
Multisystem inflammatory syndrome in children (MIS-C) in COVID19صقري بن شاهين
Multisystem inflammatory syndrome in children (MIS-C) as found recently in pandemic covid19 (SARS-CoV-2) within pediatric field as it was labeled as Kawasaki like disease.
objectives:
Introduction
Definition
Epidemiology
Pathophysiology
Clinical presentaion
Evaluation
management
Minji Kang, MD
Infectious Diseases Fellow
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
Covid19 and pregnancy: There are case reports of preterm birth in women with COVID-19 but it is unclear whether the preterm birth was always iatrogenic, or whether some were spontaneous.
As per ICMR Guidelines Pregnant women do not appear more likely to contract the infection than the general population. However, pregnancy itself alters the body’s immune system and response to viral infections in general, which can occasionally be related to more severe symptoms and this will be the same for COVID-19. Reported cases of COVID-19 pneumonia in pregnancy are milder and with good recovery.Pregnant women with heart disease are at highest risk (congenital or acquired). In other types of coronavirus infection (SARS, MERS), the risks to the mother appear to increase in particular during the last trimester of pregnancy. There are case reports of preterm birth in women with COVID-19 but it is unclear whether the preterm birth was always iatrogenic, or whether some were spontaneous.The coronavirus epidemic increases the risk of perinatal anxiety and depression, as well as domestic violence. It is critically important that support for women and families is strengthened as far as possible; that women are asked about mental health at every contact. A small study of nine pregnant women in Wuhan, China, with confirmed COVID-19 found no evidence of the virus in their breast milk, cord blood or amniotic fluid. According to WHO, pregnant women
do not appear to be at higher risk of severe disease.
Furthermore, WHO reports that currently there is no known difference between the clinical manifestations of COVID-19 in pregnant and non-pregnant women of reproductive age
ACOG is advising caution based on the impact of other respiratory illnesses (including influenza/ SARS outbreak of 2002–2003), stating that “pregnant women should be considered an at-risk population for COVID-19
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
2. • Coronavirus disease 2019 (COVID-19) is an illness caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
• In the United States and throughout the world, fewer cases of COVID-
19 have been reported in children than in adults.
• Whereas children comprise 22% of the US population, approximately
14% of all cases of COVID-19 reported to the Centers for Disease
Control and Prevention (CDC) were among children (as of May 12,
2021).
• Most cases in children are mild, and treatment consists of supportive
care.
INTRODUCTION
3. INTRODUCTION
• The American Academy of Pediatrics reports children represent 14%
of all confirmed cases in the 49 states reporting by age.
• Over 3.9 million children have tested positive in the United States
since the onset of the pandemic as of May 13, 2021.
• This represents an overall rate of 5,187 cases per 100,000 children.
During the 2-week period of April 29 to May 13, 2021, there was a 3%
increase in the cumulated number of children who tested positive,
representing 120,982 new cases.
• Children were 1.3-3.1% of total reported hospitalizations, and from
0.1-1.9% of all child COVID-19 cases resulted in hospitalization
4. ETIOLOGY
Transmission
• Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is a highly
infectious virus
• The main routes of transmission are respiratory droplets and contact with
respiratory secretions and saliva.
• Aerosol particles may be another possible mode of transmission.
• SARS CoV-2 can remain viable on various surfaces for hours to days,
although transmission is much more common through respiratory droplets
than through fomites.
• Fecal shedding has been detected for several weeks after diagnosis, which
has led to concerns about fecal-oral transmission of the virus.
5. ETIOLOGY
Mother-to-child transmission
• Based on limited data, no confirmed cases of vertical mother-to-fetus
intrauterine transmission of the virus have been reported thus far.
• A multicenter study involving 16 Spanish hospitals reported outcomes of 242
pregnant women diagnosed with COVID-19 during their third trimester from
March 13 to May 31, 2020.
• The women and their 248 newborns were monitored until the infant was 1
month old.
• COVID-19–positive mothers who were hospitalized had a higher risk of ending
their pregnancy via cesarean section (P = .027).
• Newborns whose mothers had been admitted owing to their COVID-19 infection
had a higher risk of premature delivery (P = .006).
• No infants died, and no vertical or horizontal transmission was detected.
• The percentage of infants exclusively breastfed at discharge was 41.7% and was
40.4% at 1 month.
6. • To date, SARS CoV-2 has not been detected in breast milk.
• A study by Chambers et al found human milk is unlikely to transmit
SARS CoV-2 from infected mothers to infants.
• The study included 64 milk samples provided by 18 mothers infected
with COVID-19.
• Samples were collected before and after COVID-19 diagnosis.
• No replication-competent virus was detectable in any of their milk
samples compared with samples of human milk that were
experimentally infected with SARS CoV-2.
7. Family clustering
• Family clustering appears to play a major role in disease transmission.
• In one study, just over half of children with coronavirus disease 2019
(COVID-19) in China had evidence of transmission through family
clustering.
• Most of the children in the US data also had exposure to a patient
with COVID-19 in the household or community.
Community transmission
• Cruz and Zeichner suggested that children have a role in community-
based viral transmission.
• They noted that children are more likely than adults to have upper
respiratory tract involvement, including nasopharyngeal carriage.
• They may also have prolonged respiratory and fecal shedding.
8. Epidemiology
• Fewer cases of coronavirus disease 2019 (COVID-19) have been diagnosed in
children than in adults
• The majority of the pediatric cases have been mild. Whereas children comprise
22% of the US population, approximately 14% of all cases of COVID-19 reported
to the Centers for Disease Control and Prevention (CDC) were among children (as
of May 12, 2021).
• The number and rate of cases in children in the US have been steadily
increasing.[1]
• The true incidence of SARS-CoV-2 infection in children is not known, owing to the
lack of widespread testing and the prioritization of testing for adults and those
with severe illness.
• Hospitalization rates in children are significantly lower than hospitalization rates
in adults with COVID-19, which suggests that children may have less severe illness
from COVID-19 compared with adults.[1]
9. Epidemiology
• The American Academy of Pediatrics reports children represent 14%
of all confirmed cases in the 49 states reporting by age.
• Over 3.9 million children have tested positive in the United States
since the onset of the pandemic as of May 13, 2021.
• This represents an overall rate of 5,187 cases per 100,000 children.
• During the 2-week period of April 29 to May 13, 2021, there was a
3% increase in the cumulated number of children who tested positive,
representing 120,982 new cases.
• Race-, sex-, and age-related demographics
• No racial predilection has been observed in children
10. INCUBATION PERIOD
• The typical incubation period of coronavirus disease 2019 (COVID-19)
ranges from 1 to 14 days, with an average of 3-7 days.
• However, longer incubation periods (up to 24 days) have been
reported.
• In most of the early pediatric cases reported from China, the patient
had a close contact with COVID-19 or was part of a family cluster of
cases.
11. Physical examination
• Lu et al evaluated 171 children with confirmed severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection who were treated at the
Wuhan Children’s Hospital in China.
• They reported that the most common signs and symptoms were cough
(48.5% of patients), pharyngeal erythema (46.2%), and fever (41.5%).
Other signs and symptoms included the following:
Diarrhea (8.8% of patients)
Fatigue (7.6%)
Rhinorrhea (7.6%)
Vomiting (6.4%)
Nasal congestion (5.3%)
About 29% of patients had tachypnea on admission
42% had tachycardia.
Slightly more than 2% of children had an oxygen saturation of < 92% during their
hospitalization.
Rash has been reported in patients with COVID-19.
12. The following conditions indicate a greater likelihood of severe
disease:
• Dyspnea: Respiration rate of >50 breaths/min in children aged 2-12 months; >40
breaths/min in children aged 1-5 years; >30 breaths/min in patients older than 5
years old
• Persistent high fever for 3-5 days.
• Poor mental response, lethargy, disturbance of consciousness, and other changes
of consciousness.
• Abnormally increased levels of enzymes, such as myocardial and liver enzymes
and lactate dehydrogenase.
• Unexplained metabolic acidosis.
• Chest imaging findings indicating bilateral or multi-lobe infiltration, pleural
effusion, or rapid progression of conditions during a very brief period.
• Age younger than 3 months.
• Extrapulmonary complications.
• Coinfection with other viruses or bacteria.